UBS Group »

Definium Therape shares owned by UBS Group

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.3M 494k 18.90

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Marshall Wace
AWM Investment Company
Candriam Luxembourg S.C.A.
Vanguard Capital Management
Vanguard Portfolio Management
Bank of New York Mellon
Nuveen
Vanguard Fiduciary Trust
Ensign Peak Advisors
UBS Group
Deutsche Bank Aktiengesellschaft
Jane Street
BIT Capital GmbH

View all funds holding Definium Therape